- Home
- GRDN vs INVA Comparison
GRDN vs INVA Comparison
Compare GRDN & INVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRDN
- INVA
- Stock Information
- Founded
- GRDN 2004
- INVA 1996
- Country
- GRDN United States
- INVA United States
- Employees
- GRDN N/A
- INVA N/A
- Industry
- GRDN Retail-Drug Stores and Proprietary Stores
- INVA Biotechnology: Pharmaceutical Preparations
- Sector
- GRDN Consumer Staples
- INVA Health Care
- Exchange
- GRDN Nasdaq
- INVA Nasdaq
- Market Cap
- GRDN 1.4B
- INVA 1.2B
- IPO Year
- GRDN 2024
- INVA 2004
- Fundamental
- Price
- GRDN $20.67
- INVA $18.58
- Analyst Decision
- GRDN Strong Buy
- INVA Buy
- Analyst Count
- GRDN 2
- INVA 1
- Target Price
- GRDN $22.50
- INVA N/A
- AVG Volume (30 Days)
- GRDN 229.7K
- INVA 722.9K
- Earning Date
- GRDN 02-15-2025
- INVA 02-27-2025
- Dividend Yield
- GRDN N/A
- INVA N/A
- EPS Growth
- GRDN N/A
- INVA 46.55
- EPS
- GRDN N/A
- INVA 0.99
- Revenue
- GRDN $1,170,907,000.00
- INVA $352,745,000.00
- Revenue This Year
- GRDN $18.05
- INVA $16.20
- Revenue Next Year
- GRDN $9.55
- INVA N/A
- P/E Ratio
- GRDN N/A
- INVA $18.76
- Revenue Growth
- GRDN 16.86
- INVA 21.46
- 52 Week Low
- GRDN $14.16
- INVA $14.33
- 52 Week High
- GRDN $25.74
- INVA $21.28
- Technical
- Relative Strength Index (RSI)
- GRDN N/A
- INVA 63.73
- Support Level
- GRDN N/A
- INVA $17.01
- Resistance Level
- GRDN N/A
- INVA $17.53
- Average True Range (ATR)
- GRDN 0.00
- INVA 0.28
- MACD
- GRDN 0.00
- INVA 0.18
- Stochastic Oscillator
- GRDN 0.00
- INVA 98.12
About GRDN Guardian Pharmacy Services Inc. Class A Common Stock
Guardian Pharmacy Services Inc is a leading, highly differentiated pharmacy services company that provides an extensive suite of technology-enabled services designed to help residents of LTCFs adhere to their appropriate drug regimen, which in turn helps reduce the cost of care and improve clinical outcomes. The company emphasizes high-touch, individualized clinical, drug dispensing and administration capabilities that are tailored to serve the needs of residents in historically lower acuity LTCFs, such as ALFs, and .BHFs.
About INVA Innoviva Inc.
Innoviva Inc is a company with a portfolio of royalties and innovative healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.